CA1323300C - Combinaison thrombolitiquement active de pro-urokinase et d'urokinase - Google Patents

Combinaison thrombolitiquement active de pro-urokinase et d'urokinase

Info

Publication number
CA1323300C
CA1323300C CA000548421A CA548421A CA1323300C CA 1323300 C CA1323300 C CA 1323300C CA 000548421 A CA000548421 A CA 000548421A CA 548421 A CA548421 A CA 548421A CA 1323300 C CA1323300 C CA 1323300C
Authority
CA
Canada
Prior art keywords
pro
unit dosage
injection
urokinase
infusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000548421A
Other languages
English (en)
Inventor
Dieter Welzel
Helmut Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vascular Laboratory Inc
Original Assignee
Vascular Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868623823A external-priority patent/GB8623823D0/en
Priority claimed from GB868628741A external-priority patent/GB8628741D0/en
Priority claimed from GB878707551A external-priority patent/GB8707551D0/en
Priority claimed from GB878715678A external-priority patent/GB8715678D0/en
Application filed by Vascular Laboratory Inc filed Critical Vascular Laboratory Inc
Application granted granted Critical
Publication of CA1323300C publication Critical patent/CA1323300C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000548421A 1986-10-03 1987-10-01 Combinaison thrombolitiquement active de pro-urokinase et d'urokinase Expired - Fee Related CA1323300C (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8623823 1986-10-03
GB868623823A GB8623823D0 (en) 1986-10-03 1986-10-03 Therapeutic lysis of fibrin blood clots
GB868628741A GB8628741D0 (en) 1986-12-02 1986-12-02 Therapeutic lysis of fibrin blood clots
GB8628741 1986-12-02
GB878707551A GB8707551D0 (en) 1987-03-30 1987-03-30 Therapeutic lysis of fibrin blood clots
GB8707551 1987-03-30
GB878715678A GB8715678D0 (en) 1987-07-03 1987-07-03 Therapeutic lysis of fibrin blood clots
GB8715678 1987-07-03

Publications (1)

Publication Number Publication Date
CA1323300C true CA1323300C (fr) 1993-10-19

Family

ID=27449820

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000548421A Expired - Fee Related CA1323300C (fr) 1986-10-03 1987-10-01 Combinaison thrombolitiquement active de pro-urokinase et d'urokinase

Country Status (19)

Country Link
KR (1) KR960002738B1 (fr)
AU (1) AU7932587A (fr)
BE (1) BE1002058A4 (fr)
CA (1) CA1323300C (fr)
CH (1) CH678599A5 (fr)
DE (1) DE3731776A1 (fr)
DK (1) DK519287A (fr)
FI (1) FI874320A (fr)
FR (1) FR2605225B1 (fr)
GR (1) GR871528B (fr)
HU (1) HUT47032A (fr)
IL (1) IL84061A0 (fr)
IT (1) IT1230114B (fr)
LU (1) LU87007A1 (fr)
MY (1) MY101943A (fr)
NL (1) NL8702234A (fr)
NO (1) NO874143L (fr)
PT (1) PT85848B (fr)
SE (1) SE466531B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.

Also Published As

Publication number Publication date
KR880004821A (ko) 1988-06-27
FR2605225A1 (fr) 1988-04-22
FI874320A0 (fi) 1987-10-01
HUT47032A (en) 1989-01-30
KR960002738B1 (ko) 1996-02-26
FR2605225B1 (fr) 1994-02-04
DK519287A (da) 1988-04-04
LU87007A1 (fr) 1988-05-03
NO874143L (no) 1988-04-05
CH678599A5 (fr) 1991-10-15
SE8703788L (sv) 1988-04-04
PT85848A (en) 1987-11-01
IL84061A0 (en) 1988-03-31
DK519287D0 (da) 1987-10-02
PT85848B (en) 1990-01-12
IT1230114B (it) 1991-10-07
GR871528B (en) 1988-02-23
SE466531B (sv) 1992-03-02
NO874143D0 (no) 1987-10-01
IT8748444A0 (it) 1987-10-02
AU7932587A (en) 1988-04-14
FI874320A (fi) 1988-04-04
DE3731776A1 (de) 1988-05-05
MY101943A (en) 1992-02-15
BE1002058A4 (fr) 1990-06-12
NL8702234A (nl) 1988-05-02
SE8703788D0 (sv) 1987-10-01

Similar Documents

Publication Publication Date Title
FI120182B (fi) Trombolyyttisesti aktiivisten proteiinien ja antikoagulanttien yhdistelmiä ja niiden käyttöjä
RU96119944A (ru) Комбинация тромболитически активных белков и антикоагулянтов и их применение
US5055295A (en) Lysis of fibrin blood clots with urokinase and pro-urokinase
CA1337046C (fr) Agent thrombolytique
Dupe et al. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis
CA1323300C (fr) Combinaison thrombolitiquement active de pro-urokinase et d'urokinase
GB2197195A (en) Urokinase compositions for treating thrombosis
US6372213B2 (en) Method of treating sickle cell disease or thalassemia
US20050143283A1 (en) Activated protein c formulations
JP2958650B2 (ja) 新規な血栓溶解組成物
CA1303987C (fr) Compositions pharmaceutiques ayant une activite thrombolytique
JP2783367B2 (ja) ヘパリン含有製剤
EP1137432B1 (fr) Utilisation de la protein c pour le traitement du purpura thrombopenique et du syndrome hemolytique et uremique
Mola et al. A pilot study of pro-urokinase in the treatment of deep vein thrombosis
EP0352897B1 (fr) Médicaments contenant le TPA
US5174994A (en) Pharmaceutical composition having thrombolytic activity
Sasahara Fundamentals of fibrinolytic therapy
JPH08268910A (ja) プロテインcの皮下投与のための薬剤
JPH0769921A (ja) 網膜血管閉塞症予防治療剤
Bonnier et al. CARDIAC ENZYME RELEASE AFTER FIBRINOLYTIC THERAPY WITH INTRAVENOUS (iv) APSAC OR INTRACORONARY (ie) STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
EP0332346A2 (fr) Combinaisons, pharmaceutiques comprenant un dérivé acide pipéridinyle cyclopentylehepténique

Legal Events

Date Code Title Description
MKLA Lapsed